国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Gabapentin
Zentiva Pharma UK Ltd
N02BF01
Gabapentin
400mg
Oral capsule
Oral
Schedule 3 (CD No Register Exempt Safe Custody)
Valid as a prescribable product
BNF: 04080100; GTIN: 5000283630920
PACKAGE LEAFLET: INFORMATION FOR THE USER GABAPENTIN ZENTIVA 100MG, 300MG & 400MG CAPSULES (GABAPENTIN) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What gabapentin is and what it is used for 2. What you need to know before you take gabapentin 3. How to take gabapentin 4. Possible side effects 5. How to store gabapentin 6. Contents of the pack and other information 1. WHAT GABAPENTIN IS AND WHAT IT IS USED FOR This medicine is called Gabapentin Zentiva and it contains the active substance Gabapentin (called gabapentin throughout this leaflet). Gabapentin is used to treat: • _ VARIOUS FORMS OF EPILEPSY (SEIZURES THAT ARE INITIALLY LIMITED TO CERTAIN PARTS OF THE BRAIN, WHETHER THE SEIZURE SPREADS TO _ _OTHER PARTS OF THE BRAIN OR NOT)._ Your doctor will prescribe gabapentin if your current treatment is no longer fully controlling your epilepsy. You should take gabapentin in addition to your current treatment. If your doctor considers that it is necessary, gabapentin can also be used on its own to treat adults and children over 12 years of age. •_ PERIPHERAL NEUROPATHIC PAIN (LONG LASTING PAIN CAUSED BY DAMAGE TO THE NERVES)._ A variety of different diseases can cause this type of pain (primarily occurring in the legs and/or arms), such as diabetes (high blood sugar) or shingles (disease caused by the varicella virus). These pains may be felt as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles etc. 2. WHAT YOU NEED TO KNOW BEFORE Y 阅读完整的文件
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gabapentin Medreich 400mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 400mg hard capsule contains 400mg of gabapentin. Excipient with known effect: Each 400mg hard capsule contains 67.333 mg of lactose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM ‘Capsule, hard’. Size ‘0’ orange/orange hard gelatin capsule marked ‘MG 400’ 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS EPILEPSY Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalisation in adults and children aged 6 years and above (see section 5.1) Gabapentin is indicated as monotherapy in the treatment of partial seizures with and without secondary generalisation in adults and adolescents aged 12 years and above. TREATMENT OF PERIPHERAL NEUROPATHIC PAIN Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: For all indications a titration scheme for the initiation of therapy is described in Table 1, which is recommended for adults and adolescents aged 12 years and above. Dosing instructions for children under 12 years of age are provided under a separate sub-heading later in this section. TABLE 1: DOSING CHART - INITIAL TITRATION Day 1 Day 2 Day 3 300mg once a day 300mg two times a day 300mg three times a day Discontinuation of gabapentin: In accordance with current clinical practice, if gabapentin has to be discontinued it is recommended this should be done gradually over a minimum of 1 week independent of the indication. Epilepsy: Epilepsy typically requires long-term therapy. Dosage is determined by the treating physician according to individual tolerance and efficacy. _Adults and adolescents:_ In clinical trials, the effective dosing range was 900 to 3600 mg/day. Therapy may be initiated by titrating the dose as described in Table 1 阅读完整的文件